Donna J. Brogan Lecture in Biostatistics

This lecture honors Donna J. Brogan, an outstanding former faculty member and chair in the Department of Biostatistics at the Rollins School of Public Health. The lecture is made possiblein large part by the generous support of Donna and her colleagues and friends. Donna has been Professor Emerita since her retirement from Emory in 2004.  

History of the Donna J. Brogan Lecture in Biostatistics

The Donna J. Brogan Lecture in Biostatistics was established in late 2004 by the Biostatistics Department of the Rollins School of Public Health of Emory University to honor the outstanding career of Dr. Donna Jean Brogan, a biostatistics/statistics faculty member at Emory for 34 years. Emory recognized Dr. Brogan's inspiring career with a gala retirement celebration in 2004. Her colleagues, friends and family members marked this occasion with gifts to support what would become the annual Donna J. Brogan Lecture in Biostatistics. These lectures, always in April, may be related to Dr. Brogan's research interests in sample surveys, breast cancer epidemiology and statistical education. Since the inception of the lectures in 2006, preeminent scholars and lecturers in biostatistics have visited Emory to deliver the lecture in honor of Dr. Brogan.

In 2010, Dr. Brogan made a significant contribution to establish an endowment fund that will provide funding continuity for the lecture. Her endowment, combined with generous gifts from colleagues and friends, makes possible one of only two named lectures at the Rollins School of Public Health. If you wish to contribute to the endowment fund for this lecture, click here. Please choose Rollins School of Public Health for "Select Direction" and Donna J. Brogan Lecture in Biostatistics for "Select Fund".

2017 Donna J. Brogan Lecture

April 10, 2017 at 4:00pm, reception following

Marie Davidian

The Right Treatment for the Right Patient (at the Right Time): Precision Medicine Through Treatment Regimes and SMARTs

Clinicians have long recognized that patients are different, and thus treatment decisions must be based on individual patient characteristics. Precision medicine seeks to make clinical decision-making evidence-based, providing health care professionals with principled decision support. In the treatment of chronic diseases and disorders such as cancer or depression, a series of treatment decisions must be made at milestones and events in the disease/disorder process and in response to the evolving condition of the patient. The goal is to make the "best" sequence of decisions so as to achieve the most beneficial expected outcome for the patient

An extensive body of statistical research exists on the development of data-based optimal, evidence-based tailored decision strategies (treatment regimes) and clinical trial designs suited to this purpose. I will provide an overview of how these methods work and provide a fundamental framework for precision medicine.

For more information, click here.